Navigation Links
Baxa Corporation Introduces ExactaMix™ 1200 Automated Compounder for Sterile, Multi-Ingredient Solutions
Date:11/9/2010

"The ExactaMix 1200 dispels the myth that only large healthcare facilities and hospitals can take advantage of the safety and efficiency of proven, cutting-edge automated compounding technology," said Laura Zoerner, Senior Product Manager at Baxa Corporation.  "With the addition of the 12-port compounder, we now offer a wider range of solutions with globally recognized ExactaMix Technology. Now virtually any hospital can afford automated compounding for therapies such as TPN, cardioplegia and dialysis and epidural solutions to achieve both accuracy and speed -- while maintaining USP <797> compliance and delivering exactly right doses."

In its 45th year, the MCM takes place December 5 – 9, 2010 at the Anaheim Convention Center in Anaheim, California.  In addition to ExactaMix 1200, Baxa will showcase its extensive line of solutions that efficiently and safely deliver more than 450,000 doses each day, including its DoseEdge™ Pharmacy Workflow Management System.  Over 5 million doses have been processed by DoseEdge in US hospitals to date.  DoseEdge has prevented more than 100,000 preparation errors through barcode verification of every ingredient drug and best-practice compounding process management.  To view technical videos or download educational materials on FormularyPlus enhancements for DoseEdge, visit www.baxa.com/doseedge.

Baxa Corporation reliably and consistently enables pharmacists at more than 3,000 hospitals worldwide to safely prepare and administer intravenous therapies.  To learn more about the ExactaMix 1200, visit www.baxa.com/exactamix.  For additional information, to request a product brochure or download a free, educational white paper, visit www.baxa.com, call 800-567-2292 or email

SOURCE Baxa Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. CEL-SCI Corporation Releases Letter to Shareholders
3. Alfacell Corporation to Present at UBS Global Life Sciences Conference
4. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
5. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
6. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
7. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
8. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
10. Immunosyn Corporation Releases SF-1019 Study Results
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 The Physician-Patient Alliance for ... July 28, 2015, "Surviving Your Hospital Stay: Physician-Patient ... Patient Safety." A sentence was omitted ... "PPAHS is a member of the National ... more information on the National Coalition to Promote ...
(Date:7/31/2015)... LONDON , July 31, 2015 ... to decades of experience, the domestic pharmaceutical industry is ... today manufacture products to high international standards. ... well known is in sub-Saharan Africa: Morocco has quietly ... after South Africa . Indeed, Moroccan ...
(Date:7/31/2015)... , July 31, 2015  Xencor, Inc. (NASDAQ: ... monoclonal antibodies for the treatment of autoimmune diseases, asthma ... of Yujiro S. Hata to its board ... in business and corporate development is a tremendous asset ... president and chief executive officer of Xencor. "Xencor faces ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... 16 Berlin Heart Inc. today announced,its EXCOR(R) Pediatric ... ongoing IDE clinical trial in the United,States of America. ... the Investigational Plan for the IDE study of the ... approval for the prospective,IDE study to begin initially at ...
... Australia, Oct. 16 Cytopia Limited (ASX:,CYT) will ... two important,scientific meetings this month., Dr Emmanuelle ... a,lecture entitled Targeted JAK2 Inhibitors for Myeloproliferative Disorders,at ... Australia and New,Zealand, in Perth, Australia, on 21 ...
Cached Medicine Technology:Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 2Berlin Heart's EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval 3Cytopia Scientific Presentations on JAK2 Inhibitor Program 2
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of ... Panel on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto ... in this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, ...
(Date:7/31/2015)... ... ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle and black ... Exilis non-surgical fat reduction in New York. Due to its unparalleled level of ... Many patients travel to New York to get their non-surgical skin tightening and ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... , ... July 31, 2015 , ... M3 USA MDLinx.com, ... to launch three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology ... Exam Prep from MDLinx makes preparing for the exam easy and painless. MDLinx ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3
... cholesterol lowering drugs known as statins may help prevent future ... The study is published in the August 2, 2011, print ... American Academy of Neurology. "Because the cause of ... drugs are often not used to prevent further strokes or ...
... , MONDAY, Aug. 1 (HealthDay News) -- Teens are ... in or go to school in neighborhoods with many fast ... study finds. Researchers compared 2007 data on junk food ... of junk food outlets, such as fast food restaurants, convenience ...
... By Amanda Gardner HealthDay Reporter , MONDAY, Aug. ... who have been prescribed a controlled medication such as Oxycontin ... are misusing the drugs, a new study has found. ... abuse other substances and to start giving or selling drugs ...
... , Prostate cancer is the number two killer of American men, ... affects more than 2 million American men, and in 2010 there ... kills, but even for those who survive it, the world is ... and depression are common after-effects of prostate cancer, and until now ...
... By Serena Gordon HealthDay Reporter , MONDAY, Aug. ... of the omega 3 fatty acid DHA during pregnancy, their ... indicates. At 1 month and 3 months of age, ... in the womb experienced cold symptoms, compared to about 45 ...
... of Technology (MIT) have developed a new imaging system ... changes in the esophagus or colon. The new system, ... Biomedical Optics Express , is based on an ... a way to see below the surface with 3-D, ...
Cached Medicine News:Health News:Cholesterol-lowering drugs may help prevent recurrent strokes in younger people 2Health News:With Junk Food Stores Nearby, Teens May Eat More of It 2Health News:When Teens Abuse Prescriptions, Addiction Often Follows 2Health News:When Teens Abuse Prescriptions, Addiction Often Follows 3Health News:Prenatal Omega-3 Fatty Acid Supplements May Cut Babies' Colds 2Health News:Prenatal Omega-3 Fatty Acid Supplements May Cut Babies' Colds 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 4
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps straight ends size 3.5"....
Removal Forceps, very fine pointed tips, with textured jaws, ideal for grasping wet sutures....
Forceps, extra delicate, straight....
Medicine Products: